[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100607699":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":10,"centralContacts":18,"locations":24,"responsibleParty":39,"collaborators":44,"id":55,"slug":56,"hasResults":57,"nctId":58,"briefTitle":59,"officialTitle":59,"acronym":10,"eligibilityCriteria":60,"healthyVolunteers":57,"sex":61,"minAge":62,"maxAge":63,"enrollmentInfo":64,"targetDuration":10,"studyType":67,"phases":10,"briefSummary":68,"conditions":69,"keywords":10,"overallStatus":27,"whyStopped":10,"lastUpdateSubmitDate":71,"lastUpdatePostDateStruct":72,"startDateStruct":75,"completionDateStruct":77,"leadSponsor":79,"locationsCount":80},{"fullName":5,"class":6},"Shanghai Jiao Tong University School of Medicine","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Adrenal cohort",null,"Aged between 18 and 75 years; diagnosed with adrenal diseases, including primary aldosteronism, pheochromocytoma, Cushing's syndrome, congenital adrenal hyperplasia, adrenocortical carcinoma, etc.; in stable condition, capable of tolerating all examinations and follow-ups required by the study.",[13],"Other: Receive adrenal surgery, radiotherapy, and\u002For medication therapy based on diagnosis and subtype classification.",[15],{"type":6,"name":16,"description":16,"armGroupLabels":17,"otherNames":10},"Receive adrenal surgery, radiotherapy, and\u002For medication therapy based on diagnosis and subtype classification.",[9],[19],{"name":20,"role":21,"phone":22,"phoneExt":10,"email":23},"Yiran Jiang","CONTACT","0086-021-64370045","jyr11662@rjh.com.cn",[25],{"facility":26,"status":27,"city":28,"state":10,"zip":10,"country":29,"countryCode":30,"cosmosGeoPoint":31,"geoPoint":36,"contacts":37},"Jiang yiran","RECRUITING","Shanghai","China","CN",{"type":32,"coordinates":33},"Point",[34,35],121.45806,31.22222,{"lat":35,"lon":34},[38],{"name":20,"role":21,"phone":22,"phoneExt":10,"email":23},{"type":40,"investigatorFullName":41,"investigatorTitle":42,"investigatorAffiliation":43,"oldNameTitle":10,"oldOrganization":10},"PRINCIPAL_INVESTIGATOR","Wang Weiqing","Director of the Department of Endocrinology, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine","Ruijin Hospital",[45,48,50,52],{"name":46,"class":47},"Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine","UNKNOWN",{"name":49,"class":6},"RenJi Hospital",{"name":51,"class":6},"Shanghai Zhongshan Hospital",{"name":53,"class":54},"Shanghai Public Health Clinical Center","OTHER_GOV","100607699","shanghai-clinical-cohort---adrenal-disease-100607699",false,"NCT07191951","Shanghai Clinical Cohort - Adrenal Disease","Inclusion Criteria:\n\n* A signed and dated informed consent form\n* Commitment to abide by the study procedures and cooperate with the implementation of the entire study process\n* Patients diagnosed with adrenal diseases, including aldosteronism, Cushing's syndrome, pheochromocytoma, adrenocortical carcinoma, and congenital adrenal hyperplasia; regardless of whether they have received adrenal surgery, radiotherapy, and\u002For medication therapy\n* Aged between 18 and 75 years\n\nExclusion Criteria:\n\n* Subjects meeting any of the following criteria will be excluded from this study:\n* Refuse to sign the informed consent form\n* Patients without adrenal diseases\n* Have specified diseases or conditions (physical or psychological, identified through physical examination) that warrant exclusion from the study","ALL","18 Years","75 Years",{"count":65,"type":66},600,"ESTIMATED","OBSERVATIONAL","As a vital organ responsible for producing life-sustaining hormones, the adrenal gland is associated with a wide range of diseases. These diseases affect multiple systems throughout the body and carry a high rate of mortality and disability. Current diagnosis and treatment face several challenges: significant variability in hormone testing results, inaccurate localization via imaging techniques, unclear molecular characteristics of adrenal tumors, and difficulty in determining prognosis through pathology. Therefore, establishing a clinical research cohort for adrenal diseases is essential. Such a cohort will enable in-depth exploration of disease mechanisms, identification of disease subtypes, optimization of diagnostic criteria, evaluation of treatment efficacy, advancement of personalized medicine, and formulation of prevention and treatment strategies.",[70],"Adrenal Disease","2025-11-14",{"date":73,"type":74},"2025-11-17","ACTUAL",{"date":76,"type":74},"2025-07-25",{"date":78,"type":66},"2025-12-31",{"name":5,"class":6},1]